Si02

Si02, founded in 2011, is a primary packaging company specializing in advanced solutions for the pharmaceutical and biotech sectors. The company leverages its proprietary vyterialTM coating technology, a unique fusion of glass and polymer properties, to create packaging that ensures the safe distribution of critical life-saving drugs. This innovative approach addresses the drawbacks of traditional packaging materials, offering enhanced barrier properties against moisture and oxygen. Si02's commitment to research and development is underscored by over 300 patents, driving the creation of cutting-edge products designed for preservation and efficacy.

The company's product portfolio includes specialized syringes, vials, and blood collection tubes, all manufactured within state-of-the-art facilities located in Auburn, Alabama. Operating across 3 locations, Si02 employs between 500-1,000 professionals dedicated to delivering sustainable and effective packaging solutions. This operational scale and focus on quality enable them to meet the stringent demands of the healthcare industry. Meet Si02's team to understand the expertise driving their innovation and production.

Financially, Si02 reported a revenue of $29.1M. The company has also secured funding, including $2M in debt financing in 2020. Si02 operates within a competitive landscape, facing rivals such as Kerr Dental and Labcon, and focuses on providing disruptive technology for molecular diagnostics, liquid biopsies, and vaccine delivery. Their solutions are crucial for advancing healthcare and consumer health applications. Explore financial highlights for a deeper dive into their fiscal performance and market position.